78 related articles for article (PubMed ID: 22884897)
21. miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment.
Lopez JP; Lim R; Cruceanu C; Crapper L; Fasano C; Labonte B; Maussion G; Yang JP; Yerko V; Vigneault E; El Mestikawy S; Mechawar N; Pavlidis P; Turecki G
Nat Med; 2014 Jul; 20(7):764-8. PubMed ID: 24908571
[TBL] [Abstract][Full Text] [Related]
22. Qualification of LSP1-2111 as a Brain Penetrant Group III Metabotropic Glutamate Receptor Orthosteric Agonist.
Cajina M; Nattini M; Song D; Smagin G; Jørgensen EB; Chandrasena G; Bundgaard C; Toft DB; Huang X; Acher F; Doller D
ACS Med Chem Lett; 2014 Feb; 5(2):119-23. PubMed ID: 24900783
[TBL] [Abstract][Full Text] [Related]
23. Dopamine and extinction: a convergence of theory with fear and reward circuitry.
Abraham AD; Neve KA; Lattal KM
Neurobiol Learn Mem; 2014 Feb; 108():65-77. PubMed ID: 24269353
[TBL] [Abstract][Full Text] [Related]
24. Substance abuse, memory, and post-traumatic stress disorder.
Tipps ME; Raybuck JD; Lattal KM
Neurobiol Learn Mem; 2014 Jul; 112():87-100. PubMed ID: 24345414
[TBL] [Abstract][Full Text] [Related]
25. Role of mGluR4 in acquisition of fear learning and memory.
Davis MJ; Iancu OD; Acher FC; Stewart BM; Eiwaz MA; Duvoisin RM; Raber J
Neuropharmacology; 2013 Mar; 66():365-72. PubMed ID: 22884897
[TBL] [Abstract][Full Text] [Related]
26. Neural substrates for the distinct effects of presynaptic group III metabotropic glutamate receptors on extinction of contextual fear conditioning in mice.
Dobi A; Sartori SB; Busti D; Van der Putten H; Singewald N; Shigemoto R; Ferraguti F
Neuropharmacology; 2013 Mar; 66():274-89. PubMed ID: 22643400
[TBL] [Abstract][Full Text] [Related]
27. Histone acetylation rescues contextual fear conditioning in nNOS KO mice and accelerates extinction of cued fear conditioning in wild type mice.
Itzhak Y; Anderson KL; Kelley JB; Petkov M
Neurobiol Learn Mem; 2012 May; 97(4):409-17. PubMed ID: 22452925
[TBL] [Abstract][Full Text] [Related]
28. Amygdaloid metabotropic glutamate receptor subtype 7 is involved in the acquisition of conditioned fear.
Siegl S; Flor PJ; Fendt M
Neuroreport; 2008 Jul; 19(11):1147-50. PubMed ID: 18596617
[TBL] [Abstract][Full Text] [Related]
29. Potentiation of GluN2C/D NMDA receptor subtypes in the amygdala facilitates the retention of fear and extinction learning in mice.
Ogden KK; Khatri A; Traynelis SF; Heldt SA
Neuropsychopharmacology; 2014 Feb; 39(3):625-37. PubMed ID: 24008353
[TBL] [Abstract][Full Text] [Related]
30. Neural organization of the defensive behavior system responsible for fear.
Fanselow MS
Psychon Bull Rev; 1994 Dec; 1(4):429-38. PubMed ID: 24203551
[TBL] [Abstract][Full Text] [Related]
31. Orthosteric versus allosteric GPCR activation: the great challenge of group-III mGluRs.
Flor PJ; Acher FC
Biochem Pharmacol; 2012 Aug; 84(4):414-24. PubMed ID: 22554564
[TBL] [Abstract][Full Text] [Related]
32. Measures of anxiety, sensorimotor function, and memory in male and female mGluR4⁻/⁻ mice.
Davis MJ; Haley T; Duvoisin RM; Raber J
Behav Brain Res; 2012 Apr; 229(1):21-8. PubMed ID: 22227508
[TBL] [Abstract][Full Text] [Related]
33. A novel selective metabotropic glutamate receptor 4 agonist reveals new possibilities for developing subtype selective ligands with therapeutic potential.
Goudet C; Vilar B; Courtiol T; Deltheil T; Bessiron T; Brabet I; Oueslati N; Rigault D; Bertrand HO; McLean H; Daniel H; Amalric M; Acher F; Pin JP
FASEB J; 2012 Apr; 26(4):1682-93. PubMed ID: 22223752
[TBL] [Abstract][Full Text] [Related]
34. Opposing efficacy of group III mGlu receptor activators, LSP1-2111 and AMN082, in animal models of positive symptoms of schizophrenia.
Wierońska JM; Stachowicz K; Acher F; Lech T; Pilc A
Psychopharmacology (Berl); 2012 Apr; 220(3):481-94. PubMed ID: 21952670
[TBL] [Abstract][Full Text] [Related]
35. Automated assessment of pavlovian conditioned freezing and shock reactivity in mice using the video freeze system.
Anagnostaras SG; Wood SC; Shuman T; Cai DJ; Leduc AD; Zurn KR; Zurn JB; Sage JR; Herrera GM
Front Behav Neurosci; 2010; 4():. PubMed ID: 20953248
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
